Is patient-prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement?
a Department of Cardiac Surgery, Clinica Capio, Albacete, Spain b Department of Cardiac Surgery, Policlinica Gipuzkoa, San Sebastian, Spain *Corresponding author. Tel.: +34 9672427100; fax: +34 967245183. E-mail address : stefano_urso{at}inwind.it (S. Urso). A best evidence topic in cardiac surgery...
Gespeichert in:
Veröffentlicht in: | Interactive cardiovascular and thoracic surgery 2009-09, Vol.9 (3), p.510-518 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | a Department of Cardiac Surgery, Clinica Capio, Albacete, Spain
b Department of Cardiac Surgery, Policlinica Gipuzkoa, San Sebastian, Spain
*Corresponding author. Tel.: +34 9672427100; fax: +34 967245183. E-mail address : stefano_urso{at}inwind.it (S. Urso).
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: is patient-prosthesis mismatch an independent risk factor for 30-day and mid-term overall mortality in adult patients undergoing aortic valve replacement (AVR)? Altogether, almost 400 papers were found using the reported search, of which 22 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. The majority of the selected articles have focused their analysis on moderate mismatch defined mostly by the presence of an indexed effective orifice area (IEOA) 0.85 cm 2 /m 2 . In fact, because of the low incidence of patients with severe mismatch, these were often grouped for the statistical analysis with patients with moderate mismatch. Only six studies have analyzed the specific condition of severe mismatch (IEOA0.65 cm 2 /m 2 ) is an independent risk factor for 30-day or mid-term overall mortality for adult patients undergoing AVR. An exception could be represented by patients with poor ejection fraction, a condition that can make moderate mismatch a predictor of overall mortality after AVR. On the other hand, severe mismatch is a predictor of overall 30-day or mid-term mortality for patients undergoing AVR independently from the presence of poor ejection fraction. In conclusion, our review suggests that the condition of severe PPM should be always avoided, while the presence of moderate mismatch could be tolerated in patients with normal ejection fraction without any impact on overall survival.
Key Words: Aortic valve; Heart valve prosthesis; Mortality
Related Articles
eComment: Prosthesis-patient mismatch: a need to individualize the preventive strategy according to the baseline characteristics of the patient
Philippe Pibarot
Interactive CardioVascular and Thoracic Surgery 2009 9: 518.
[Full Text]
[PDF]
eCo |
---|---|
ISSN: | 1569-9293 1569-9285 |
DOI: | 10.1510/icvts.2009.207597 |